diagnode-3.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /admin/ Disallow: /manager/ Disallow: /ScriptResource.axd Disallow: /WebResource.axd Disallow: /scriptresource.axd Disallow: /webresource.axd Sitemap: | ||
Meta Tags
| Title | Diagnode-3 Diabetes |
| Description | Privacy The DIAGNODE-3 study will investigate whether an investigational drug called Diamyd® (rhGAD65) is able to preserve the body’s own insulin-producing capacity by halting or delaying the autoimmune attack on the insulin-producing cells (beta cells) in |
| Keywords | Diagnode-3, Diamyd®, Type 1 diabetes, lymph node, Diamyd, diabetes |
Server Information
| WebSite | |
| Host IP | 185.133.206.250 |
| Location | - |
Related Websites
| Site | Rank |
More to Explore
diagnode-3.com Valuation
|
US$1,365
Last updated: 2023-05-20 00:24:32
diagnode-3.com has Semrush global rank of 0. diagnode-3.com has an estimated worth of US$ 1,365, based on its estimated Ads revenue. diagnode-3.com receives approximately 157 unique visitors each day. Its web server is located in -, with IP address 185.133.206.250. According to SiteAdvisor, diagnode-3.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,365 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$37 |
| Yearly Ads Revenue | US$453 |
| Daily Unique Visitors | 10 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| diagnode-3.com. | A | 1800 | IP: 185.133.206.250 |
| diagnode-3.com. | AAAA | 1800 | IPV6: 2a01:a560:1::67 |
| diagnode-3.com. | NS | 1800 | NS Record: ns1.beebyte.net. |
| diagnode-3.com. | NS | 1800 | NS Record: ns2.beebyte.net. |
| diagnode-3.com. | NS | 1800 | NS Record: ns3.beebyte.net. |
HtmlToTextCheckTime:2023-05-20 00:24:32
| Toggle navigation Sweden Czech Republic Germany Poland Spain Netherlands Hungary Estonia ESTONIA ESTONIA (Russian) Recently diagnosed with type 1 diabetes? Consider taking part in the DIAGNODE-3 study The DIAGNODE-3 study The Phase III clinical trial DIAGNODE-3 is recruiting recently diagnosed type 1-diabetes patients in selected clinics in a number of European countries. Information in local languages will be available as soon as the ethic committee in a participating country has approved the information material. Please choose your country in the top navigation menu to learn more, and to see how you can participate in the study. Participating clinics in approved countries The trial sponsor Diamyd Medical has obtained approval from competent authorities for conducting the Phase III trial DIAGNODE-3. The patient recruitment information is approved by the national Ethics Committees. EudraCT Number: 2021-002731-32 © Diamyd Medical AB Cookies/Privacy Share This Page select Facebook |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 146 Content-Type: text/html; charset=UTF-8 Location: https://diagnode-3.com/ Vary: Accept-Encoding Date: Thu, 15 Dec 2022 08:51:49 GMT HTTP/2 200 cache-control: private content-length: 30609 content-type: text/html; charset=utf-8 vary: Accept-Encoding date: Thu, 15 Dec 2022 08:51:49 GMT |
diagnode-3.com Whois Information
Domain Name: DIAGNODE-3.COM Registry Domain ID: 2606116138_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2022-03-21T04:09:39Z Creation Date: 2021-04-19T08:03:03Z Registry Expiry Date: 2023-04-19T08:03:03Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Registrar Abuse Contact Email: domainabuse@tucows.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.BEEBYTE.NET Name Server: NS2.BEEBYTE.NET Name Server: NS3.BEEBYTE.NET DNSSEC: unsigned >>> Last update of whois database: 2022-12-15T08:41:50Z <<< |